Your browser doesn't support javascript.
loading
Neumonías neonatales / Neonatal pneumonia
Balboa de Paz, F; Rueda Esteban, S; Paredes Mercado, C; Barbosa Gomes, E.
Affiliation
  • Balboa de Paz, F; Hospital Clínico <<San Carlos>>. Servicio de Pediatría. Madrid. España
  • Rueda Esteban, S; Hospital Clínico <<San Carlos>>. Servicio de Pediatría. Madrid. España
  • Paredes Mercado, C; Hospital Clínico <<San Carlos>>. Servicio de Pediatría. Madrid. España
  • Barbosa Gomes, E; Hospital <<David Bernardino>>. Luanda. Angola
Acta pediatr. esp ; 66(10): 481-486, nov. 2008. ilus
Article in Spanish | IBECS | ID: ibc-59586
Responsible library: ES1.1
Localization: BNCS
RESUMEN
El pulmón constituye el lugar más común de asentamiento de los microorganismos causales de sepsis del recién nacido. Este origen corresponde tanto a la vida prenatal y al parto como a la vida posnatal. Es por ello por lo que deben observarse estrechamente los signos sugerentes de dificultad respiratoria en el neonato, con el fin de llevar a cabo un diagnóstico y un tratamiento precoces. Estos cuadros se asocian a una gran morbilidad, pues se estima en unas 800.000 las muertes neonatales al año debidas a infecciones respiratorias en países en vías de desarrollo. En nuestro medio se estima que la incidencia es menor del 1%, pero sería cercana al 10% en niños con comorbilidad si se englobasen tanto los recién nacidos con peso adecuado para la edad gestacional como los de bajo peso. Además, en la práctica clínica se observa que casi en la totalidad de los cuadros sépticos existe afectación neumónica más o menos significativa tanto clínica como radiológica. En este artículo revisamos los diversos aspectos y retos que plantean las neumonías neonatales (en especial los gérmenes más habituales), y su enfoque terapéutico(AU)
ABSTRACT
The lung is the most common site of entry of the microorganisms causing sepsis in the newborn infant. This invasion can occur during the prenatal period and labor, as well as during the postnatal period. Thus, we must closely monitor signs suggestive of respiratory distress in the newborn infant in order to establish an early diagnosis and initiate treatment. These conditions are associated with a high rate of morbidity, and it is estimated that, in developing countries, approximately 800,000 neonatal deaths a year are due to respiratory infections. In our population, the incidence is calculated to be less than 1%, but it would be nearly10% in children with co-morbidity if the population includes those with a birth weight adequate for their gestational age and full term and premature infants. In addition, in clinical practice, it is observed that in nearly every case of sepsis, there is more or less significant evidence of pulmonary involvement in both the clinical and radiological examinations. In this article, we review the different aspects and challenges associated with neonatal pneumonia, focusing especially on the most common microorganisms and the therapeutic approach (AU)
Subject(s)
Search on Google
Collection: National databases / Spain Health context: SDG3 - Health and Well-Being / SDG3 - Target 3.3 End transmission of communicable diseases / SDG3 - Target 3.4 Reduce premature mortality due to noncommunicable diseases / SDG3 - Target 3.2 Reduce avoidable death in newborns and children under 5 Health problem: Target 3.2: Reduce avoidable death in newborns and children under 5 / Pneumonia / Other Respiratory Diseases / Infections / Neonatal Healthcare / Noncommunicable Diseases Database: IBECS Main subject: Pneumonia / Prognosis / Respiratory Distress Syndrome, Newborn / Respiratory Tract Infections / Gentamicins / Morbidity / Ampicillin Type of study: Prognostic study / Screening study Limits: Female / Humans / Male / Infant, Newborn Language: Spanish Journal: Acta pediatr. esp Year: 2008 Document type: Article Institution/Affiliation country: Hospital >/Angola / Hospital Clínico >/España
Search on Google
Collection: National databases / Spain Health context: SDG3 - Health and Well-Being / SDG3 - Target 3.3 End transmission of communicable diseases / SDG3 - Target 3.4 Reduce premature mortality due to noncommunicable diseases / SDG3 - Target 3.2 Reduce avoidable death in newborns and children under 5 Health problem: Target 3.2: Reduce avoidable death in newborns and children under 5 / Pneumonia / Other Respiratory Diseases / Infections / Neonatal Healthcare / Noncommunicable Diseases Database: IBECS Main subject: Pneumonia / Prognosis / Respiratory Distress Syndrome, Newborn / Respiratory Tract Infections / Gentamicins / Morbidity / Ampicillin Type of study: Prognostic study / Screening study Limits: Female / Humans / Male / Infant, Newborn Language: Spanish Journal: Acta pediatr. esp Year: 2008 Document type: Article Institution/Affiliation country: Hospital >/Angola / Hospital Clínico >/España
...